| Vitamin E: action, metabolism and perspectives E Herrera, C Barbas Journal of physiology and biochemistry 57, 43-56, 2001 | 732 | 2001 |
| Gut microbiota disturbance during antibiotic therapy: a multi-omic approach AE Pérez-Cobas, MJ Gosalbes, A Friedrichs, H Knecht, A Artacho, ... Gut 62 (11), 1591-1601, 2013 | 690 | 2013 |
| Transcription factor NRF2 as a therapeutic target for chronic diseases: a systems medicine approach A Cuadrado, G Manda, A Hassan, MJ Alcaraz, C Barbas, A Daiber, ... Pharmacological reviews 70 (2), 348-383, 2018 | 609 | 2018 |
| Imbalanced OPA1 processing and mitochondrial fragmentation cause heart failure in mice T Wai, J García-Prieto, MJ Baker, C Merkwirth, P Benit, P Rustin, ... Science 350 (6265), aad0116, 2015 | 514 | 2015 |
| Understanding the antimicrobial mechanism of TiO2-based nanocomposite films in a pathogenic bacterium A Kubacka, MS Diez, D Rojo, R Bargiela, S Ciordia, I Zapico, JP Albar, ... Scientific reports 4 (1), 4134, 2014 | 459 | 2014 |
| Metabolomics in cancer biomarker discovery: current trends and future perspectives EG Armitage, C Barbas Journal of pharmaceutical and biomedical analysis 87, 1-11, 2014 | 406 | 2014 |
| Method validation strategies involved in non-targeted metabolomics S Naz, M Vallejo, A García, C Barbas Journal of Chromatography A 1353, 99-105, 2014 | 365 | 2014 |
| Antibiotic use and microbiome function M Ferrer, C Méndez-García, D Rojo, C Barbas, A Moya Biochemical pharmacology 134, 114-126, 2017 | 346 | 2017 |
| Quality assurance procedures for mass spectrometry untargeted metabolomics. a review D Dudzik, C Barbas-Bernardos, A García, C Barbas Journal of pharmaceutical and biomedical analysis 147, 149-173, 2018 | 331 | 2018 |
| Chromatographic analysis of α-tocopherol and related compounds in various matrices FJ Ruperez, D Martın, E Herrera, C Barbas Journal of chromatography A 935 (1-2), 45-69, 2001 | 331 | 2001 |
| Gas chromatography-mass spectrometry (GC-MS)-based metabolomics A Garcia, C Barbas Metabolic profiling: Methods and protocols, 191-204, 2011 | 256 | 2011 |
| Bryostatin-1 for latent virus reactivation in HIV-infected patients on antiretroviral therapy C Gutiérrez, S Serrano-Villar, N Madrid-Elena, MJ Pérez-Elías, ME Martín, ... Aids 30 (9), 1385-1392, 2016 | 234 | 2016 |
| Renal tubule Cpt1a overexpression protects from kidney fibrosis by restoring mitochondrial homeostasis V Miguel, J Tituaña, JI Herrero, L Herrero, D Serra, P Cuevas, C Barbas, ... The Journal of clinical investigation 131 (5), 2021 | 207 | 2021 |
| Validation of a HPLC quantification of acetaminophen, phenylephrine and chlorpheniramine in pharmaceutical formulations: capsules and sachets A Marın, E Garcıa, A Garcıa, C Barbas Journal of Pharmaceutical and Biomedical Analysis 29 (4), 701-714, 2002 | 205 | 2002 |
| From sample treatment to biomarker discovery: A tutorial for untargeted metabolomics based on GC-(EI)-Q-MS A Mastrangelo, A Ferrarini, F Rey-Stolle, A Garcia, C Barbas Analytica chimica acta 900, 21-35, 2015 | 190 | 2015 |
| Controlling the quality of metabolomics data: new strategies to get the best out of the QC sample J Godzien, V Alonso-Herranz, C Barbas, EG Armitage Metabolomics 11, 518-528, 2015 | 188 | 2015 |
| Correlative and quantitative 1H NMR-based metabolomics reveals specific metabolic pathway disturbances in diabetic rats S Zhang, GAN Gowda, V Asiago, N Shanaiah, C Barbas, D Raftery Analytical biochemistry 383 (1), 76-84, 2008 | 186 | 2008 |
| Exploring the human microbiome from multiple perspectives: factors altering its composition and function D Rojo, C Méndez-García, BA Raczkowska, R Bargiela, A Moya, M Ferrer, ... FEMS microbiology reviews 41 (4), 453-478, 2017 | 182 | 2017 |
| Missing value imputation strategies for metabolomics data EG Armitage, J Godzien, V Alonso‐Herranz, Á López‐Gonzálvez, ... Electrophoresis 36 (24), 3050-3060, 2015 | 170 | 2015 |
| In vitro effects of a flavonoid-rich extract on LDL oxidation M Viana, C Barbas, B Bonet, MV Bonet, M Castro, MV Fraile, E Herrera Atherosclerosis 123 (1-2), 83-91, 1996 | 168 | 1996 |
